Breaking News

Home / Unlabelled / Medtronic completes $1.1B acquisition after meeting FTC conditions

Medtronic completes $1.1B acquisition after meeting FTC conditions

May 14, 2022
Not rendering correctly? View this email as a web page here.

With the FTC's conditional approval, Medtronic completes its $1.1B acquisition of Intersect ENT

To get approval for the deal, Medtronic agreed to sell an Intersect subsidiary to soothe the FTC's concerns.

Combining behavioral & data sciences to optimize chronic disease management

By Yoni Nevo Friday, May 13, 2022 7:50 PM

Working behind the scenes to examine what motivates us and what we respond to best, behavioral science applied to AI-powered technologies can create personalized success companions that aid people in making small but important steps along difficult health journeys.

Read more »

As the pandemic wanes, challenges abound for U.S. healthcare systems

By Lars Thording Friday, May 13, 2022 1:51 PM

Although some short-term problems—like a lack of ICU beds to treat Covid-19 patients—have abated, deeper issues have emerged that represent long-term challenges for U.S. health systems.

Read more »

UCB's FDA setback delays competition in U.S. with blockbuster J&J psoriasis drug

By Frank Vinluan Friday, May 13, 2022 11:17 AM

The FDA cited manufacturing issues in turning down UCB's application seeking approval for bimekizumab, an antibody drug developed to treat moderate-to-severe plaque psoriasis. Bimekizumab is already approved and available in other markets around world, but the FDA rejection delays UCB's antibody drug from competing in the U.S. for now.

Read more »
   

No comments

Subscribe to: Post Comments ( Atom )